Similar Success Rates but Lower Incidence of Telaprevir-Related Rash in HIV/HCV Coinfected as Compared to HCV-Monoinfected Patients Treated With Triple Anti-HCV Therapy

J Acquir Immune Defic Syndr. 2015 May 1;69(1):e37-40. doi: 10.1097/QAI.0000000000000541.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Coinfection / drug therapy*
  • Exanthema / chemically induced*
  • Exanthema / epidemiology*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Oligopeptides / administration & dosage
  • Oligopeptides / adverse effects*
  • Retrospective Studies

Substances

  • Antiviral Agents
  • Oligopeptides
  • telaprevir